authors
- Hughes, TP
- Cervantes, F
- Leber, Brian
- Spector, N
- Lipton, JH
- Pasquini, R
- Clementino, NCD
- Schwarer, AP
- Mahon, FX
- Rea, D
- Yeung, DT
- Kamel-Reid, S
- Bendit, I
- Acharya, S
- Collins, L
- Dalal, D
- Branford, S
ENESTCMR 4-Y RESULTS: PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND RESIDUAL DISEASE MORE LIKELY TO ACHIEVE DEEP MOLECULAR RESPONSE FOLLOWING SWITCH TO NILOTINIB (NIL)
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 1, 2015
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- Immunology (Science Metrix)
published in
- Haematologica Journal